Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system

Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Orthop Res
Auteurs principaux: Feng, Yong, Sassi, Slim, Shen, Jacson K, Yang, Xiaoqian, Gao, Yan, Osaka, Eiji, Zhang, Jianming, Yang, Shuhua, Yang, Cao, Mankin, Henry J., Hornicek, Francis J, Duan, Zhenfeng
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/
https://ncbi.nlm.nih.gov/pubmed/25348612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires